Category: ROS1+ Lung Cancer

Check Out the September 2017 Edition of our newsletter

Want to know more about what we are doing at ALCF? Read our most recent newsletter and learn more about our thoughts on healthcare reform, crowdsourcing in cancer, a new study from ALCMI and Inivata, an interview with Bonnie, upcoming events, and more. Click here to read the newsletter now

Posted by ALCF Staff on October 2nd, 2017

Patient Advocacy Strategies Evolve as Genomic Advances Change Understanding of Cancer

The ROS1ders, are throwing their energy behind creating preclinical mouse models and cells lines that will inform drug development efforts and improve understanding… Read More

Posted by ALCF Staff on September 8th, 2017

ALCMI, Champions Oncology, and ROS1ders to Launch Clinical Study

The Addario Lung Cancer Medical Institute (ALCMI), and Champions Oncology (NASDAQ: CSBR), a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, announce a research collaboration and initiation of the ALCMI-006 study, which was developed and will be conducted by ALCMI and… Read More

Posted by ALCF Staff on August 15th, 2017

Do you know a ROS1-fusion positive cancer patient?

In May, 2016, the Bonnie J. Addario Lung Cancer Foundation launched the Global ROS1 Initiative, in partnership with cancer patients whose tumors are driven by ROS1 gene fusions. These ROS1 gene fusions are abnormal changes in cells that drive the growth and spread of several different cancer types such as non-small cell lung, gastric, ovarian,… Read More

Posted by Dr. Guneet Walia on February 23rd, 2017